Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajinomoto Group Ventures is the corporate venture capital arm of Ajinomoto Co., Inc., a global leader in amino acids and food science. The venture group focuses on strategic investments in early-to-growth stage startups within the healthcare, foodtech, and sustainability sectors. By leveraging Ajinomoto's deep expertise in fermentation, biopharma services (CDMO), and specialty chemicals, the group aims to foster innovation in personalized nutrition, regenerative medicine, and green technologies. Their investment strategy is designed to create synergies between emerging technologies and Ajinomoto's global manufacturing and R&D infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajinomoto Group Ventures.